1. Home
  2. ONC vs GFI Comparison

ONC vs GFI Comparison

Compare ONC & GFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeiGene Ltd. American Depositary Shares

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$416.47

Market Cap

40.6B

Sector

Health Care

ML Signal

N/A

Logo Gold Fields Limited

GFI

Gold Fields Limited

N/A

Current Price

$35.84

Market Cap

35.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
ONC
GFI
Founded
2010
1887
Country
Switzerland
South Africa
Employees
12000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
40.6B
35.5B
IPO Year
2015
2002

Fundamental Metrics

Financial Performance
Metric
ONC
GFI
Price
$416.47
$35.84
Analyst Decision
Strong Buy
Buy
Analyst Count
27
8
Target Price
★ $465.00
$46.84
AVG Volume (30 Days)
442.0K
★ 3.6M
Earning Date
11-05-2026
08-25-2026
Dividend Yield
N/A
★ 5.27%
EPS Growth
★ 140.43
N/A
EPS
★ 0.56
N/A
Revenue
★ $238,387,000.00
N/A
Revenue This Year
$29.05
$36.55
Revenue Next Year
$15.06
$3.34
P/E Ratio
$743.85
★ $25.02
Revenue Growth
★ 22179.16
N/A
52 Week Low
$253.95
$31.11
52 Week High
$424.73
$61.52

Technical Indicators

Market Signals
Indicator
ONC
GFI
Relative Strength Index (RSI) 67.27 46.14
Support Level $341.67 $34.67
Resistance Level N/A $38.15
Average True Range (ATR) 10.70 1.20
MACD 4.37 0.21
Stochastic Oscillator 88.77 38.65

Price Performance

Historical Comparison
ONC
GFI

About ONC BeiGene Ltd. American Depositary Shares

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.

About GFI Gold Fields Limited

Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia, and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing, and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith, and South Deep, and surface-only open pit mining at Damang, Tarkwa, and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.

Share on Social Networks: